Amy Abernethy, Verily’s president of product development and chief medical officer, is leaving the company to start a non-profit aimed at revolutionizing the health care system’s data collection. The company has assured its employees that it is well-equipped to move towards her vision of speeding up product development in clinical research. However, from an external viewpoint, this move appears to be another significant shift for an organization that has spent years narrowing down its focus and finding its mission.
Source link
Amy Abernethy to step down as Verily’s chief medical officer
